![]() Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ![]() Ipsen Ipsen SA is a France-based pharmaceutical company that produces a range of various types of drugs. | ![]() Roche Roche Holding is a biotech company that providesin-vitro diagnostics and supplies solutions across various disease areas. | ![]() Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. | ![]() Vifor Pharma Vifor Pharma is a diversified group active throughout the healthcare market which, among other things, develops, manufactures, and markets pharmaceutical products. | |||
Founding Date | Founding Date 2017 | Founding Date 1996 | Founding Date 1849 | Founding Date 1929 | Founding Date 1896 | Founding Date 1988 | Founding Date 1927 | Founding Date 2014 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||||
Locations | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | Locations Boulogne-Billancourt, FR HQ Glen Waverley, AU Merelbeke, BE Hoofddorp, NL | Locations Tarrytown, US HQ Mississauga, CA München, DE Bengaluru, IN Dublin, IE Limerick, IE Tokyo, JP see more | Locations Glattbrugg, CH HQ Buenos Aires, AR Melbourne, AU Melbourne, AU Wien, AT Antwerpen, BE São Paulo, BR see more | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Bengaluru, IN HQ Bengaluru, IN Hyderabad, IN Visakhapatnam, IN Dublin, IE Kuala Lumpur, MY Puchong, MY see more | |
Employees | Employees 8007% increase | Employees 101,7033% decrease | Employees 83,0005% increase | Employees 5,300 | Employees 103,613 | Employees 12,2563% increase | Employees 2,200 | Employees 904 | Employees 16,54510% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 171.2 b | Valuation ($) 9.3 b | Valuation ($) N/A | Valuation ($) 88.8 b | Valuation ($) N/A | Valuation ($) 7.9 b | Valuation ($) N/A |
Twitter followers | Twitter followers 2.1 k | Twitter followers 301.8 k | Twitter followers 491.8 k | Twitter followers 5.9 k | Twitter followers 247.2 k | Twitter followers 32.5 k | Twitter followers N/A | Twitter followers 1.8 k | Twitter followers 21.8 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 12 | Number of tweets (last 30 days) 4 | Number of tweets (last 30 days) 16 | Number of tweets (last 30 days) 7 | Number of tweets (last 30 days) 33 | Number of tweets (last 30 days) 4 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 18 | Number of tweets (last 30 days) 16 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 3.3 | Average likes per tweet (last 30 days) 8.5 | Average likes per tweet (last 30 days) 63.4 | Average likes per tweet (last 30 days) 2.4 | Average likes per tweet (last 30 days) 9.8 | Average likes per tweet (last 30 days) 4.8 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2.3 | Average likes per tweet (last 30 days) 4.1 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 75% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 84.85% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 83.33% | Percentage of tweets with engagement (last 30 days) 100% |
Employee Rating | Employee Rating 3.7 | Employee Rating 4.2 | Employee Rating 4.2 | Employee Rating 4 | Employee Rating 4.2 | Employee Rating 4 | Employee Rating 3 | Employee Rating 3.6 | Employee Rating 3.8 |
Financial | |||||||||
Revenue (est.) | Revenue (est.) CHF97.1m (FY, 2022) | Revenue (est.) $51.8b (FY, 2022) | Revenue (est.) $100.3b (FY, 2022) | Revenue (est.) €3.2b (FY, 2022) | Revenue (est.) CHF63.3b (FY, 2022) | Revenue (est.) $12.2b (FY, 2022) | Revenue (est.) CHF1.8b (FY, 2021) | Revenue (est.) $61.3m (FY, 2023) | Revenue (est.) ₹109.3b (FY, 2023) |
Cost of goods | Cost of goods CHF6.3m (FY, 2022) | Cost of goods $8.3b (FY, 2022) | Cost of goods $34.3b (FY, 2022) | Cost of goods €423.6m (FY, 2022) | Cost of goods CHF15.3b (FY, 2022) | Cost of goods $1.6b (FY, 2022) | Cost of goods CHF498.7m (FY, 2021) | Cost of goods $131.3m (FY, 2023) | Cost of goods ₹39.3b (FY, 2023) |
Gross profit | Gross profit CHF90.8m (FY, 2022) | Gross profit $44.3b (FY, 2022) | Gross profit $66b (FY, 2022) | Gross profit €2.9b (FY, 2022) | Gross profit CHF51.1b (FY, 2022) | Gross profit $10.6b (FY, 2022) | Gross profit CHF1.3b (FY, 2021) | Gross profit ($70m) (FY, 2023) | Gross profit ₹78.5b (FY, 2023) |
Net income | Net income (CHF827.9m) (FY, 2022) | Net income $7b (FY, 2022) | Net income $31.4b (FY, 2022) | Net income €603.1m (FY, 2022) | Net income CHF13.5b (FY, 2022) | Net income $4.3b (FY, 2022) | Net income CHF265.4m (FY, 2021) | Net income ($1.1b) (FY, 2023) | Net income ₹6.4b (FY, 2023) |
Operating ⚠ | |||||||||
Patients | Patients N/A | Patients 10 m (FY, 2022) | Patients N/A | Patients N/A | Patients 14.2 m (FY, 2022) | Patients N/A | Patients N/A | Patients N/A | Patients N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2021) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 4 (Q2, 2021) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 25 (FY, 2021) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 5 (Q2, 2021) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 27 (FY, 2021) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 1 (Q2, 2021) | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 10 (FY, 2021) | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 1 (Q2, 2021) | Registration Phase Products N/A |
Funding | |||||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7.8b | Total funding raised $ 53.9m | Total funding raised N/A | Total funding raised $ 1.9b | Total funding raised N/A |
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyPfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyIpsen SA is a France-based pharmaceutical company that produces a range of various types of drugs.
View companyRoche Holding is a biotech company that providesin-vitro diagnostics and supplies solutions across various disease areas.
View company